Phytomedicine : international journal of phytotherapy and phytopharmacology
Cure8 research brief
Why This Matters
People with ulcerative colitis may be interested because the study describes a natural compound that reduced inflammation and disease signs in a mouse model and acted through the gut microbiota and immune pathways — areas relevant to IBD management and research.
Who Should Pay Attention
Researchers studying microbiome-based therapies, basic-science investigators of immune pathways in IBD, clinicians following emerging preclinical therapies, and patients interested in microbiome research (not clinical advice).
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study (abstract) reports that a pectic polysaccharide extracted from rhubarb (RP-2) reduced inflammation and disease severity in a DSS-induced mouse model of ulcerative colitis. The authors characterized RP-2 structurally, observed prolonged retention in inflamed colon tissue, and showed microbiota changes (enrichment of SCFA-producing bacteria).
Antibiotic depletion reduced RP-2’s protective effects, and mechanistic experiments implicate suppression of the TLR4/MyD88/NF-κB pathway and restoration of Th17/Treg balance. RP-2 effects were tested in cell culture (RAW264.7 macrophages) and in mice with chemically induced colitis; the abstract does not report human data.
The protective effect depended on the gut microbiota and was associated with improved barrier markers and reduced pro-inflammatory cytokines in the model. This is a preclinical, mechanistic report of a natural product in animals and cells; it suggests a microbiota–metabolite–immune–barrier axis but does not provide clinical efficacy or safety data in people.
Do not interpret as a treatment recommendation.
Keep In Mind
This is an abstract of preclinical laboratory research (cell and DSS mouse model). Findings in animal models often do not translate directly to humans; no clinical trials or human safety data are reported here.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationPhytomedicine : international journal of phytotherapy and phytopharmacology
AuthorsLi H, Ke Q, Feng J +7 more
Study typeIm, journal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedAug 19, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Extracellular Vesicles Derived from Elaeocarpus braceanus Alleviate DSS-Induced Ulcerative Colitis in Mice Through Multiple Pathways
This study describes a new plant-derived nanoparticle (EBDEVs) that reduced inflammation and improved colon health in a mouse model of ulcerative colitis and altered the gut microbiota — early evidence that may guide...
Fufang Tongye Shaoshang You repairs ulcerative colitis in mice caused by DSS based on the balanced strategy of "inflammation inhibition-microbiota regulation-mucosa protection".
People with UC may be interested because the study identifies a traditional herbal formulation that reduced disease markers in a mouse model and changed gut microbiota and inflammatory pathways (IL‑17), suggesting...
Extracellular Vesicles Derived from Elaeocarpus braceanus Alleviate DSS-Induced Ulcerative Colitis in Mice Through Multiple Pathways.
The study suggests a novel plant-derived nanoparticle approach reduced inflammation and repaired barrier function in a mouse model of colitis and changed the gut microbiome — a potential early-stage route for new IBD...